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Abstract
Background: Carbon monoxide (CO) is produced endogenously, and can also be acquired from many exogenous
sources: ie. cigarette smoking, automobile exhaust. Although toxic at high levels, low level production or exposure
lends to normal physiologic functions: smooth muscle cell relaxation, control of vascular tone, platelet aggregation,
anti- inflammatory and anti-apoptotic events. In pregnancy, it is unclear at what level maternal CO exposure
becomes toxic to the fetus. In this study, we hypothesized that CO would be embryotoxic, and we sought to
determine at what level of chronic CO exposure in pregnancy embryo/fetotoxic effects are observed.
Methods: Pregnant CD1 mice were exposed to continuous levels of CO (0 to 400 ppm) from conception to
gestation day 17. The effect on fetal/placental growth and development, and fetal/maternal CO concentrations
were determined.
Results: Maternal and fetal CO blood concentrations ranged from 1.12- 15.6 percent carboxyhemoglobin (%COHb)
and 1.0- 28.6%COHb, respectively. No significant difference was observed in placental histological morphology or in
placental mass with any CO exposure. At 400 ppm CO vs. control, decreased litter size and fetal mass (p < 0.05),
increased fetal early/late gestational deaths (p < 0.05), and increased CO content in the placenta and the maternal
spleen, heart, liver, kidney and lung (p < 0.05) were observed.
Conclusions: Exposure to levels at or below 300 ppm CO throughout pregnancy has little demonstrable effect on
fetal growth and development in the mouse.
Background
At very high levels, carbon monoxide (CO) is a toxic
gas; exogenous inhalation of CO levels higher than 3%
(30 000 ppm) leads to lethal outcomes [1], but this is
usually through accidental inhalation of smoke or
exhaust in enclosed spaces [2]. Interestingly, CO is pro-
duced endogenously at low concentrations with normal
physiologic functions: smooth muscle cell relaxation,
control of vascular tone [3], platelet aggregation [4],
anti-inflammatory and anti-apoptotic events [5].
Endogenously, the oxidization of heme by the enzyme
heme oxygenase (HO) produces equimolar amounts of
CO, iron and biliverdin [6]. Heme is a major structural
component of hemoglobin (Hb), and the abundance of
this molecule in red blood cells allows for the largest
amount of heme for degradation. Additionally, CO has
been measured in a number of tissues; most abundantly
i nm u s c l e ,h e a r t ,l i v e r ,s p l e e n ,a n dk i d n e y[ 7 ] ;a l t h o u g h
both endogenous levels and functionality are not well
understood.
Exogenous inhalation of CO leads to its preferential
binding with Hb, producing carboxyhemoglobin
(COHb). This binding is in direct competition with
molecular oxygen (O2), and binds to Hb with 250 times
greater affinity than O2 [8]. This effect shifts the O2 dis-
sociation curve to the left [9], limiting the release of O2
to the tissues, and can lead to hypoxia, or further, the
asphyxiating effects of CO poisoning. Measurable CO
levels in non- smoking adults are 0 to 1.5% COHb [10],
whereas people who smoke may increase their %COHb
levels to 14% [11,12]. Refer to Table 1 for a comparison
of reference CO levels.
Although many negative effects are associated with
cigarette smoking in pregnancy, 17% of Canadian
women smoked cigarettes in their pregnancy between
1995 and 2001 [13]. Of the greater than 4800 toxic
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any medium, provided the original work is properly cited.chemicals identified within cigarette smoke [14], a major
combustible product is CO. It readily crosses the pla-
centa and can combine with fetal Hb and tissue heme
moieties [15]. When pregnant sheep were exposed to
CO, a lag period was found before fetal CO levels began
to rise, but shortly afterwards, they matched and even
surpassed those of their mother. Fetal hypoxia may
result at high levels of maternal CO exposure, however,
the level at which maternal CO exposure becomes a
fetal threat is unknown.
In vitro, researchers have isolated HO in human pla-
cental and umbilical cord tissues [16], suggesting that
CO is produced in this tissue. We have shown that CO,
at levels similar to those found in umbilical cord blood
at delivery, is capable of placental vasorelaxation [17].
As the levels of CO in pregnant women who smoke are
increased, this suggests an exacerbation of placental
vasorelaxation, while we have shown that nicotine has
no effect on the basal feto/placental perfusion pressure
[18]. These results suggest that CO may play a role in
placental development and/or its regulation of placental
hemodynamics [19].
A few studies have examined the effects of CO expo-
sure in pregnancy, but they yield conflicting results in
different animal species [20-23]. Studies conducted in
pregnant wister rats exposed dams to one CO dose
above 1000 ppm for varying lengths of time throughout
pregnancy, observing decreased fetal weights and litter
size [20,21]. It is likely at such high exposures that CO
poisoning occurred, however venous CO levels (57%
COHb recorded) were measured only in one of the stu-
dies, with no mention of the method by which this
number was obtained [21]. Studies conducted at 500
ppm CO and below [22-24] yield maternal %COHb
levels of roughly 28 [7], approximating more closely %
COHb of adults smoking roughly two packs of cigar-
ettes/day (up to 14%) [25]. The results from each of
these studies are difficult to compare, as dosing
mechanisms, lengths and amounts of CO concentrations
given to the animals vary between groups.
In the present study, we hypothesized that CO would
be embryotoxic. We investigated the effect of chronic
CO exposure to mice in pregnancy, and sought the level
at which no maternal or feto/embryotoxic effects were
demonstrable.
Methods
Ethics Statement
Experimental procedures were carried out according to
the University Animal Care Committee of Queen’sU n i -
versity and was approved by the Queen’sU n i v e r s i t y
Ethics Committee (REB no. Smith 2007-052- Or).
Animals and Husbandry
Timed matings of CD1 mice (Charles River, USA),
female (6-8 weeks old) and males (5-7 weeks old), were
performed overnight. Females were weighed and placed
into a regulated CO-dosing chamber on GD1 (morning
detection of a vaginal plug). Food and water were pro-
vided ad libitum.
Carbon Monoxide Concentrations
Concentrations of CO administered were 0, 25, 60, 100,
150, 200 250, 300 and 400 ppm in ambient air. At each
concentration a minimum of six pregnant female mice
were utilized. Room air was collected using a compres-
sor (Panther Compact 106, Silent Air Compressor,
Texas, USA) and passed through a Norgren air dryer
(Littleton, CO USA). The dry air was mixed with 10%
CO gas (Praxair, Kingston, ON) using flow meters (Ali-
cat Scientific, Tucson, AZ USA), and adjusted to the
specific CO concentration required, using a Gas Mixing
software Program (Qubit Systems Inc, Kingston, ON).
The air was bubbled through distilled water, reintrodu-
cing humidity levels of 40-50% (animal care regulations),
and monitored using a Humidity Sensor (Vernier rela-
tive humidity sensor, Mississauga, ON, CAN) and its
software (Vernier Logger Lite Software, Mississauga,
ON, CAN). This sensor also ensured the cage tempera-
ture was maintained at 25°C. The air mixture was
vented into a tightly- sealed plastic aquarium, in which
the mouse cage was placed, and exhausted out of the
chamber into the room’s air filter system. The chamber
air was changed a minimum of 10 times per hour (flow
rate 7000 ml/min). The cage was changed twice weekly
by research personnel, at which time the CO adminis-
tration was stopped (20 minute maximum). Air samples
were collected at least twice weekly from the aquarium
air- port, and measured using a gas-solid chromatogra-
phy machine (GC) (Peak Performer 1, Palo Alto, San
Francisco, USA), as previously described[26], ensuring
CO levels matched the desired concentrations.
Table 1 Reference Carbon Monoxide levels in humans
and various environmental sources
Subject/Source CO level Source
Non smoker 0-1.5% COHb [10]
Smoker Up to 14%COHb [11,12]
Natural urban air level 1-30 ppm [15]
Levels found in homes 0.5- 5 ppm [42]
Cigarette Smoke 20 000-60 000 ppm [15]
Alveolar Concentration in smoker 300-400 ppm [15]
Car Exhaust without catalytic
converter
30 000- 60 000
ppm
[15]
*Parts per million (ppm) by volume (100 ppm = 0.01% of CO in the air)
*Percent carboxyhemoglobin (%COHb) is the amount of CO bound to total
haemoglobin
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Female mice were anesthetised on GD17 by intraperito-
neal injection of 10 mg/g of 2-2-2-Tribromoethanol
(T48402, Sigma Aldrich, Canada). Upon reaching a sur-
gical plane of anaesthesia, maternal blood was drawn by
retro-orbital blood collection using a glass pipette, trans-
ferred to a microcentrifuge tube containing 10 microli-
ter (μl) of 1430 U/ml sodium heparin (Sigma Aldrich,
H0777), and placed immediately on ice. Mice were then
perfused (gravity perfusion) through the left ventricle for
15 minutes with either phosphate buffered saline (PBS)
(minimum of four mice/experiment) or 4% paraformal-
dehyde (PFA) (minimum two mice/experiment).
Blood CO measurement
Hemoglobin was measured within 5 minutes of blood
collection using a Hemocue Hb 201 (Hemocue, Swe-
den). Amber vials (2 ml) (Sigma- Aldrich Ltd) capped
(Chromatographic Specialties C223710C) with 8 mm
silica septa (Chromatographic Specialties, C13302) and
containing 20 μl of 2% sulfosalycylic acid (Sigma
Aldrich, Cat no. 86193) were purged with 21%O2/5%
CO2/balance N2 (Praxair, Kingston, ON) sent through a
catalytic converter (to reduce any CO present). Between
0.1 μla n d1μl of blood (depending on the level of CO
administration) was added using a gas tight Hamilton
syringe and repeater system (Hamilton, USA). Triplicate
vials per blood sample were prepared and set on ice for
60-120 minutes. Carbon monoxide levels were read
using a GC and expressed as a percentage of total Hb
using the following equation:
%COHb = (volCO/(Hb ∗ 1.368)] ∗ 100% [10] (1)
where “vol CO” is milliliters of CO bound to 1L of
blood, Hb is total Hb concentration in the blood (g/L)
and 1.368 is the CO-binding capacity of Hb in millilitres
per gram.
PBS perfused mice
Following a 15 minute perfusion, the uterus was dis-
sected out, and all fetuses and their respective placentas
(excluding gestational losses) were removed and weighed.
Litter size was noted for each mouse. All fetuses and pla-
centas were examined for gross morphological abnormal-
ities. Fetal mortality was classified as early gestational
demise (EGD), or as a late gestational death (LGD) (Fig-
ure 1). We classified EGD as a resorbed fetus, where no
separate distinction existed between placenta and fetus
(Figure 1A), while LGD was determined by a discernible
fetus and placenta (Figure 1B). A normal fetus at gesta-
tion day 17 is shown in Figure 1C.
Figure 1 Representation of fetal early/late gestational death.A
typical fetal early gestational demise is shown in A, a fetal late
gestational death is shown in B, a normal fetus at GD17 is shown
in C.
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Three random fetuses were decapitated and blood was
collected using a heparin-coated capillary tube (Fisher
brand, Cat no. 22-260-950). The blood from the fetuses
was pooled into a microcentrifuge tube and blood proces-
sing was completed as previously described for the dams.
Tissue CO Levels
Sections of maternal organs (brain, liver, lung, kidney,
spleen, heart) and placenta were collected and placed on
ice immediately. Tissue CO measurement was per-
formed as per Vreman et al.[7].
4% PFA perfused mice
A minimum of 2 mice per experiment were perfused
with PFA. Following perfusion with 4% PFA, the uterus
was removed. Dissecting between implantation sites,
three embryos were removed from each mouse’su t e r u s ,
stored in 4% PFA for 24 hours, and transferred to 70%
ethanol until processing. Embryos were embedded in
paraffin according to standard procedures.
Each embryo (six per CO concentration) was sec-
tioned (0.4 μm thickness) a minimum of 10 times in a
saggital plane and placed on slides. Of the 10 slides, a
random selection of 5 slides were chosen and stained
with hematoxylin and eosin. Placentas were analyzed for
histological morphometric changes compared to control.
Three pictures were taken using Nikon Eclipse E800
Light Microscope and Q capture software of the whole
placenta (10X and 40X magnification) as well as the pla-
centa labyrinth (200X magnification). The placentas
were analyzed for relative proportions of labyrinth ver-
sus junctional zone and alterations in cell shape and
size. A third party anatomist was consulted on all histo-
logical slides analyses.
Statistical Analysis
Dose response curves for maternal/fetal %COHb and Hb
concentration were analyzed using linear regression ana-
lysis. The EGD and LGD data was analyzed with a chi
squared test using the fisher exact method. EGD were
compared to total implantation sites subtract EGD and
LGD, while LGD were compared to live implantation
sites subtract LGD. For this test, OpenEpi.com version
2.3.1 was used to analyze data. All other analyses were
completed using a one way analysis of variance with a
post-hoc Dunnett’s multiple comparison test, using
Graphpad prism version 6. A p-value less than 0.05 was
deemed significant for all tests. All statistical results are
reported with standard deviation.
Results
All of the required CO levels for this study were
achieved using the computerized software and were
confirmed using GC to be between 0.5 and 5.0 ppm (up
to 1.6%) of the desired CO levels.
For each CO exposure, a minimum of four mice were
perfused with PBS and two mice with PFA. The amount
of litters per experimental group for the exposures of 0,
25 and 60 ppm CO are larger than the remaining expo-
sures. This was due to a slight change in protocol fol-
lowing the beginning of the study, where we developed
a method to measure fetal blood CO levels. Therefore,
we repeated the first three experiments at 0, 25 and 60
ppm CO, in order to acquire this data.
The blood %COHb levels were positively correlated
with increasing CO concentration exposure, for both
maternal (p < 0.01) and fetal (p < 0.01) measurements
(Figure 2A). The ratio of fetal/maternal %COHb was a
mean (SD) of 1.74X (0.12), beyond 25 ppm. Addition-
ally, Hb followed the same trend as %COHb levels, and
was positively correlated with increasing CO concentra-
tions for both maternal (p < 0.01) and fetal (p < 0.01)
levels (Figure 2B).
Figure 2 Dose responses of maternal/fetal Hb and CO levels to
increasing maternal exogenous CO exposure. A positive trend
was observed with both maternal and fetal blood %COHb vs. CO
concentration exposure (A). A positive trend was observed with
both maternal and fetal Hb vs. CO concentration exposure (B).The
slope of the line significantly deviated from zero in both cases, A
and B (p < 0.05).
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with CO concentrations of 25 ppm to 300 ppm (Figure
3A). At 400 ppm CO, fetal mass was significantly lower
than that of the control (p < 0.05). Placental mass was
not found to be significantly different than the control
with any of the CO doses (p > 0.05) (Figure 3B). Litter
size was significantly reduced only at 400 ppm com-
pared to control (p < 0.05) (Table 2).
In Table 2, total implantation sites/litter did not differ
between experimental CO exposures. The number of
EGD and LGD increased with maternal CO exposure.
EGD is presented as EGD/(total implantation sites-
EGD) *100% and LGD is presented as LGD/[total
implantation sites- (LGD + EGD)]*100%. A significant
increase in number of fetal EGD was observed at 300
and 400 ppm, while LGD were found to be significant
compared to control at 400 ppm (p < 0.05). Relative risk
data and confidence intervals are listed in Table 2.
Figure 4 displays the tissue CO concentration in the
maternal heart, liver, lung, kidney and brain, for each
CO exposure. An elevation in tissue CO concentration
is observed for most tissues, as maternal CO exposure
increases. Figure 5 displays the CO levels in the placenta
and maternal spleen for each CO exposure. These
organs are shown separately as they contained at least
four times the CO level as the other tissues examined.
At 60 ppm CO exposure, significant differences (p <
0.05) are observed in both tissue samples, compared to
control tissue.
Blinded histological analysis of placental tissue did not
show any gross morphological differences between those
exposed to CO and controls (data not shown). All par-
ties analyzing histological slides noted no differences in
relative amounts of labyrinth versus junctional zone.
Additionally, no alterations in cell shape and size were
observed.
Discussion
A number of studies have evaluated the effects of CO
exposure on pregnancy; however a direct comparison of
these studies is difficult because of significant methodolo-
gic differences. For example, the method of CO delivery
varied from whole body[20-22] to nose-only inhalation
[27], time exposure (acute vs. chronic) differed; daily
time intervals or specific days of gestation. The dosing
concentrations differed, with some studies evaluating CO
levels of 1000 ppm to 10 000 ppm [20,28], well above the
toxic range. No previous study has correlated maternal/
fetal CO levels with maternal/fetal outcomes. Our study’s
aim was to use a highly regulated CO chamber system to
expose pregnant mice to chronic CO concentrations
throughout gestation, that would mimic those of smoking
adults (2-14%COHb)[25].
Maternal cigarette smoking is perhaps one of the most
common chronic methods by which CO levels are
increased, thereby exposing the fetus to greater than
normal CO levels. Our laboratory has measured a range
of COHb in maternal smokers of 1.5-9.85%COHb
(unpublished), while a level of 14%COHb has been
determined previously by other researchers [11,12].
Cigarette smoke contains an average of 4% or 40 000
ppm CO by volume [29], and during the smoking pro-
cess it becomes diluted in air, leaving the alveoli to see
roughly 400-500 ppm [15]. It is known that CO can
cross the placenta, therefore CO can affect the fetal par-
tial pressure of O2 (pO2) [15].
In the present study, the highest dose of CO yielded a
mean maternal %COHb level of 15.6, while women who
smoke heavily during pregnancy have a calculated CO
level of up to 14%COHb [11,12]. It is important to note
that in comparison with women who intermittently
smoke, and thus are affected by peaks and troughs of
high CO exposure, these mice were subjected to
elevated CO concentrations on a constant basis. The
Figure 3 Comparison of mean fetal and placental mass to
maternal exogenous CO exposure. Mean fetal mass for each CO
exposure level is displayed in figure A, with a significant decrease in
mass observed only at 400 ppm (* p < 0.05). Mean placental mass
for each CO exposure level is displayed in figure B; no significance
at any of the CO exposures was observed (p > 0.05).
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[15], therefore a smoker would have peak CO levels
directly following their smoking a cigarette, which
would slowly dissipate until the next cigarette. Also of
importance are the elevated ventilation and elimination
rates, along with increased CO uptake, present in smal-
ler mammals compared to humans [30]. As explained
by Klimisch et al.[30], the higher ventilation rates by
smaller mammals allow for a faster rate of Hb saturation
by CO. Therefore, the %COHb results observed in this
study are presumably higher than those that would be
seen in women under similar exposure. The %COHb
values cannot be evaluated directly, but can be used as
representative values to compare the mouse model with
the potential effects in pregnant women.
As an adaptation response to increased CO levels,
likely in part due to hypoxia, it is documented that
mammals will increase Hb concentration [31] in order
to increase the O2 carrying capacity of the blood. A sig-
nificant dose- response was observed with both the
maternal and fetal Hb to increasing CO exposure levels,
and one would expect a similar response in pregnant
women.
The ratio between maternal and fetal %COHb concen-
trations (1.74) is in agreement with a study conducted
by Longo and Hill [32], and similar to results recorded
by Bureau et al.[33]who showed that the ratio of fetal/
maternal COHb was 2.5 (using umbilical blood as a
fetal representative value). The Hb levels of both mater-
nal and fetal systems differ and the affinity of fetal Hb
for CO is established to be higher than that of the
maternal system [12]. This, coupled with the lower pO2
in capillary blood of the fetus versus maternal system
[12], would add to the effect of increased fetal %COHb
compared to maternal %COHb.
There is considerable variability in the effects of CO
exposure on fetal birth weight in the published litera-
ture. It is well established that pregnant women who
Table 2 The effect of maternal CO exposure on total number of early gestational demise/late gestational death
CO (ppm) Total Implantation sites/litter Total live fetuses/litter **EGD (%) RR of EGD (CI) **LGD (%) RR of LGD (CI)
0 12.8 12.6 1.12 0.56
25 12.2 11.9 2.40 2.15 (0.42, 10.95) 0.48 0.86 (0.05, 13.66)
60 12.8 12.4 1.81 1.62 (0.27, 0.96) 1.20 2.16 (0.20, 23.56)
100 14.2 13.9 0.78 0.70 (0.06, 7.63) 1.56 1.40 (0.09, 22.15)
150 13.6 13.5 0.92 0.82 (0.08, 8.95) 0.00 0.00
200 10.9 10.5 1.15 1.03 (0.09, 11.19) 2.30 1.74 (0.38, 44.76)
250 12.9 12.4 2.91 2.67 (0.44, 15.34) 0.90 1.74 (0.11, 27.49)
330 13.9 12.1 8.80* 7.88 (1.78, 34.92) 4.00 7.16 (0.85, 60.54)
400 13.7 8.2* 13.40* 12.01 (2.72, 52.94) 26.83* 48.02 (6.59, 350.20)
EGD: early gestational demise LGD: late gestational death RR: relative risk
CI: confidence interval
Statistical Analysis: Chi squared test, using the fisher exact method to compare EGD or LGD to total implantation sites - EGD or LGD and analysis of variance for
live fetuses/litter (*p < 0.05).
**Equations: EGD (%): Total EGD/(Total Implantation Sites- EGD)*100, LGD (%): Total LGD/[(Total Implantation Sites-(EGD + LGD)]*100
Figure 4 Maternal tissue CO levels in heart, liver, lungs, kidney
and brain for each CO exposure. Significance was found in the
heart tissue at CO levels ≥100 ppm, in the liver at CO levels ≥ 200 ppm,
in both the lung and kidney at the CO level of 400 ppm only and
finally in the brain at CO levels of 250 and 300 ppm only (* p < 0.05).
Figure 5 Placenta and maternal spleen tissue CO levels with
increasing CO exposure. Compared to control, significance was
observed in both placenta and spleen at CO levels ≥ 60 ppm
exposure (* p < 0.05).
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g lighter (per pack per day smoked) than a fetus born to
a non- smoking mother [34]. However, given that there
are thousands of toxic substances in cigarette smoke,
the specific role of CO in these situations cannot be
determined. Wouters et al [28] and Soothill et al.[35]
studied the human effects of increased fetal COHb on
fetal weight, with conclusions in both cases that data
was not convincing for a simple cause-effect relation-
ship. Our study found a significant decrease in birth
weight compared to control only at our highest CO
dose. Other studies have also found a decrease in birth
weight with increasing CO exposure [20-23]. Singh and
Scott found that subjecting pregnant CD-1 mice (on GD
8 to GD 18) to CO exposures of 0 to 500 ppm (control-
ling chamber levels using a CO monitor), lead to a sig-
nificant decrease in fetal weight as early as 125 ppm,
but not in a dose dependent manner [24]. This study
did not measure CO levels in either maternal or fetal
mice. Given the toxic effects demonstrated by Singh and
Scott as early as 125 ppm, which conflicts with our data,
this presents a possibility of fetal adaptation to CO
exposures when subjected from conception, rather than
mid- way through pregnancy. Future studies would be
necessary to further examine this hypothesis.
Interestingly, placental weight was not significantly
different than the control at any of the CO doses. Bis-
sonnette and Wickham [36] reported that placental CO
diffusing capacity increased significantly with greater
gestational age, and correlated with fetal weight but not
placental weight. Thus, as CO levels increased across
our experiment, no correlation was expected with pla-
cental weight. Litter size (number of healthy fetuses)
however, was significantly decreased at 400 ppm CO
exposure compared to control. In previous studies, litter
size in rats was not shown to be affected when dams
were chronically exposed to 150 ppm CO throughout
gestation [37], but was decreased when dams were
exposed to acute doses of 1000 to 1600 ppm twice daily
throughout pregnancy [20]. An increase in EGD and
LGD above 180 ppm maternal CO exposure has been
reported previously in varying animal models [23,24],
although CO exposure levels and dosing schedules were
different amongst them. In our study, while EGD proved
significant compared to control at 300 ppm, at 400 ppm,
more fetuses appeared to have died in late gestation. As
the placenta’s diffusing capacity increases with gesta-
tional age [38], perhaps fetal health was more greatly
compromised later in pregnancy with higher CO doses,
as more potent CO was able to diffuse to the fetal
circulation.
Maternal tissue CO levels proved that aside from Hb,
the gas was also accumulating in the heme- containing
molecules found throughout tissue. At 0 ppm CO, tissue
CO levels closely approximated those previously
reported [7]. Both the spleen and the placenta were the
most difficult tissues to perfuse, as their open circulation
proved difficult for the complete removal of blood. This
would explain the much higher CO levels compared to
the other tissues sampled. A dose response was observed
in both tissues. Of the remaining tissues measured, the
heart expressed the highest CO concentration, possibly
due to high myoglobin content, a heme containing pro-
tein with an affinity for CO second only to Hb [39].
In this study, at 400 ppm maternal CO exposure, a
number of toxic results were noted. Compared to con-
trol, both maternal and fetal %COHb and Hb values were
significantly increased, fetal birth weight and litter size
were significantly decreased, and EGD/LGD were signifi-
cantly increased. Maternal tissue CO levels increased as
CO doses were raised, lending to the highest measurable
CO amounts at 400 ppm. These results indicate that the
chronic CO exposure to pregnant mice, at levels above
300 ppm, results in a feto-toxic effect.
Recently, CO has come into light as a possible thera-
peutic, due to its many beneficial effects: endogenous
and exogenous CO can promote angiogenesis[40], sup-
press the release of anti-angiogenic markers[41],
decrease inflammation and apoptotic events[5], and
vasodilate blood vessels[16]. These beneficial properties
of CO may be helpful in the treatment of disorders con-
cerning angiogenesis and vascularity, including those in
pregnancy. This study is of great importance as we have
identified a fetal toxic threshold of CO in pregnancy
above 300 ppm maternal exposure. This information
can be used in future experimental designs, when exam-
ining the potential beneficial properties of CO exposure
to treat disorders of pregnancy.
Conclusions
Our study indicates that exposure to levels at or below
300 ppm CO throughout pregnancy has little demon-
strable effect on fetal growth and development in the
mouse.
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